The primary function of the Bioinformatics Core is to provide bioinformatics services and infrastructure for the MSK research community. This can range from providing complete analysis services beginning with raw data and ending with publishable results or it can consist of assisting and supporting the growing number of computational researchers with specific data analyses. A central mission is the creation and maintenance of both a repository of robust, vetted software applications and pipelines that implement the current state-of-the- art data analysis and a collection of well documented methods and best-practices. This ensures that critical analysis steps are done in a reliable, reproducible, and understandable way, freeing the laboratory-based staff to focus on the analysis that is specific to their particular experiment and saving them time and effort in re- inventing well known bioinformatics processes. This also leads to a far more cost-effective process with greater quality control. This consistency enables the institution to provide sharable and consistent results that can be further used for integrative and pan-group analysis. The Core also plays a central role in training staff in both methods and in the use of the institution?s high performance computing infrastructure. Additionally, the Bioinformatics Core provides customized computational and statistical assistance, facilities collaboration and integrative analysis via data and code sharing, enables access to institutional databases and provides applications for the creation and curation of research data. The Core trains computational and bioinformatics staff working in concert with other departments to develop and teach workshops and training seminars. Finally, the Core works on the research and development of algorithmic best practices, evaluates current applications and pipelines, and deploys new tools as new experimental methods and assays are developed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-55
Application #
10084833
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-20
Project End
2023-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
55
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Parker, Patricia A; Banerjee, Smita C; Matasar, Matthew J et al. (2018) Efficacy of a survivorship-focused consultation versus a time-controlled rehabilitation consultation in patients with lymphoma: A cluster randomized controlled trial. Cancer 124:4567-4576
Chou, Chun; Li, Ming O (2018) Re(de)fining Innate Lymphocyte Lineages in the Face of Cancer. Cancer Immunol Res 6:372-377
Scope, A; Dusza, S W; Pellacani, G et al. (2018) Accuracy of tele-consultation on management decisions of lesions suspect for melanoma using reflectance confocal microscopy as a stand-alone diagnostic tool. J Eur Acad Dermatol Venereol :
Baradaran, Rozbeh; Wang, Chongyuan; Siliciano, Andrew Francis et al. (2018) Cryo-EM structures of fungal and metazoan mitochondrial calcium uniporters. Nature 559:580-584
Patel, Sunil V; Yu, David; Elsolh, Basheer et al. (2018) Assessment of Conflicts of Interest in Robotic Surgical Studies: Validating Author's Declarations With the Open Payments Database. Ann Surg 268:86-92
Wolner, Z J; Marghoob, A A; Pulitzer, M P et al. (2018) A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma. Br J Dermatol 178:265-269
Corrias, Giuseppe; Monti, Serena; Mannelli, Lorenzo (2018) Right Upper Quadrant Pain in a 47-Year-Old Woman. Gastroenterology 154:e11-e12
Hu, Zishuo I; Shia, Jinru; Stadler, Zsofia K et al. (2018) Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations. Clin Cancer Res 24:1326-1336
Connors, Joseph M; Jurczak, Wojciech; Straus, David J et al. (2018) Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma. N Engl J Med 378:331-344
Reznik, Ed; Luna, Augustin; Aksoy, Bülent Arman et al. (2018) A Landscape of Metabolic Variation across Tumor Types. Cell Syst 6:301-313.e3

Showing the most recent 10 out of 8799 publications